Allan D. Kirk mainly investigates Immunology, Transplantation, Kidney transplantation, Internal medicine and Kidney. His research investigates the link between Immunology and topics such as Biopsy that cross with problems in Infiltration. The concepts of his Transplantation study are interwoven with issues in Immunosuppression, Islet and Sirolimus.
Allan D. Kirk has included themes like Creatinine, Immune system and Urology in his Kidney transplantation study. His Kidney research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Kidney disease. His study in Monoclonal antibody is interdisciplinary in nature, drawing from both Allotransplantation, CD154 and Isoantibodies.
Allan D. Kirk mainly focuses on Immunology, Transplantation, Immunosuppression, Immune system and Kidney transplantation. His Immunology study incorporates themes from Blockade, Belatacept and Sirolimus. His research in Transplantation intersects with topics in Kidney, Antigen and Islet.
His Immunosuppression research incorporates themes from Clinical trial, Regimen, Tacrolimus, Immune tolerance and Organ transplantation. His Kidney transplantation study combines topics in areas such as Biopsy, Pharmacology and Urology. His work carried out in the field of Monoclonal antibody brings together such families of science as CD154 and CD40.
Allan D. Kirk focuses on Immunology, Transplantation, Belatacept, Immune system and Immunosuppression. His Immunology research includes themes of Cancer research and Kidney transplantation. His Transplantation research includes elements of Intensive care medicine, Antigen and Islet.
His biological study spans a wide range of topics, including Sirolimus, Urology, Regimen, Calcineurin and Immunotherapy. His Immune system research focuses on B cell and how it connects with Carboxyfluorescein succinimidyl ester, Lymphocyte and Lymphocyte proliferation. His Immunosuppression research is multidisciplinary, relying on both Recent Thymic Emigrant, Tacrolimus, Peripheral blood mononuclear cell and Pathology.
Allan D. Kirk spends much of his time researching Immunology, Immune system, Belatacept, Calcineurin and Transplantation. The Immunology study combines topics in areas such as Sirolimus and Kidney transplantation. The study incorporates disciplines such as Kidney, Cell adhesion molecule and Physiology in addition to Immune system.
His Belatacept course of study focuses on Regimen and Urology, Immune tolerance, Myeloid and Busulfan. His Calcineurin study combines topics from a wide range of disciplines, such as Blockade, Antigen and Immunosuppression. His research integrates issues of Renal function and Islet in his study of Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Allan D. Kirk;David M. Harlan;Nicholas N. Armstrong;Thomas A. Davis.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates.
Allan D. Kirk;Allan D. Kirk;Allan D. Kirk;Linda C. Burkly;D. Scott Batty;Roxanne E. Baumgartner.
Nature Medicine (1999)
Identification of a B cell signature associated with renal transplant tolerance in humans
Kenneth A. Newell;Adam Asare;Allan D. Kirk;Trang D. Gisler.
Journal of Clinical Investigation (2010)
Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
Norma S. Kenyon;Maria Chatzipetrou;Michele Masetti;Alessandra Ranuncoli.
Proceedings of the National Academy of Sciences of the United States of America (1999)
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.
Jonathan P. Pearl;Jeremy Parris;Douglas A. Hale;Douglas A. Hale;Steven C. Hoffmann.
American Journal of Transplantation (2005)
Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).
Allan D. Kirk;Douglas A. Hale;Roslyn B. Mannon;David E. Kleiner.
Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.
Steven C. Hoffmann;Eran M. Stanley;E. Darrin Cox;Nancy Craighead.
ETHNICITY GREATLY INFLUENCES CYTOKINE GENE POLYMORPHISM DISTRIBUTION
Steven C. Hoffmann;Eran M. Stanley;E. Darrin Cox;Barbara S. DiMercurio.
American Journal of Transplantation (2002)
The Banff 2007 working classification of skin-containing composite tissue allograft pathology.
L. C. Cendales;J. Kanitakis;S. Schneeberger;S. Schneeberger;C. Burns.
American Journal of Transplantation (2008)
Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation
Ravi S. Chari;Bradley H. Collins;John C. Magee;J. Michael Dimaio.
The New England Journal of Medicine (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: